TRIPLE I NEWS

Triple I Clinical Academic Group: Infectious Disease, Immunity and Inflammation
Maridulu Budyari Gumal SPHERE: Sydney Partnership for Health, Education, Research and Enterprise 

26 FEBRUARY 2021

News

Triple I Annual Meeting
Join us for the Triple I Clinical Academic Group Annual Meeting. This will be a combined face-to-face/online meeting, with the presenters and other members encouraged to attend in person (max. 60 people). Due to anticipated attendee numbers and current COVID restrictions, the event will be held at the Scientia Building, UNSW Sydney.  

Program 2021

• Welcome and Triple I Update: Anthony Kelleher, Triple I Clinical Academic Group Leader
• Maridulu Budyari Gumal, SPHERE/AHRA Update: Rowena Tucker, Acting Executive Director
• Panel discussion: Triple I COVID response - What have we learnt
• Seed funding report back session 
• Planning and partnerships - What are the next steps?
• Summary and close: Anthony Kelleher

When: 1 April 2021 (8.30 AM - 12.30 PM)
Where: Scientia Building, UNSW and online (streaming access details TBA)

Register for face-to-face event
 

New vaccine needed for serious childhood pneumonia
A UNSW Sydney-led medical research team has called for a new vaccine, improved strategies and enhanced monitoring to combat serious complications from childhood pneumonia.
Read more
 

Academy of Social Sciences in Australia funding success
The Academy recently announced funding for collaborative projects with French researchers. Recipients include a project led by Dr Adam Craig (UNSW Sydney)
citizen science observation of arboviral-carrying mosquitos in Pacific islands.
Read more
 

Australian Government urged to invest in updated vaccine manufacturing capability
The Australian Academy of Science has urged the Australian Government to develop additional vaccine manufacturing capability within the next 12 months. They say without the ability to produce mRNA vaccines onshore, Australia and the region remain vulnerable to supply limitations. The recommendation is part of the Academy's 2021-22 pre-Federal budget submission.
Read more
 

Draft Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis
The Australia & New Zealand Musculoskeletal Clinical Trials Network has released a draft guideline on the pharmacological management of inflammatory arthritis for public consultation.
Submission deadline: 21 March 2021
Read more
 

Events & Opportunities 

Preventing HPV in low- and middle-income countries 
A special International HPV Awareness Day online event, with Kirby Institute's Dr Dorothy Machalek and Professor Andrew Vallely.
When: 2 March 2021
Read more
 

Understanding the key changes to Investigator Grants (EMCRs)
The Academy of Science EMCR Forum and the NHMRC are co-hosting an online information session on the key changes to the Investigator Grants 2021 guidelines for early and mid-career researchers.
When: 2 March 2021
Read more
 

NHMRC Investigator Grants 2021 - Insights from Assessors UNSW Panel
The UNSW Research Strategy Office is hosting a panel session for NHMRC Investigator Grant 2021 applicants, with insights from Assessors of previous peer review rounds.The sessions aims to provide additional guidance and maximise your scores against assessment criteria as you finalise your proposals. There will also be a Q&A session with the panellists and senior leadership from UNSW Medicine and Health. 
When: 4 March 2021
Read more
 

Job Opportunity: Project Officer, Clinical Trials - SPHERE Maridulu Budyari Gumal
The Project Officer will support the ongoing development and implementation of the Clinical Trials Support and Enablement Program. You will be responsible for supporting the Deputy Director in managing deliverables and deadlines
Deadline: 7 March 2021
Read more
 

Women and COVID-19: Equity and marginalisation during the pandemic
This International Women’s Day, the Kirby Institute is proud to present a webinar featuring three female leaders who have made enormous contributions to communities across Australia during the COVID-19 pandemic and beyond.
When: 9 March 2021
Read more
 

Nominations Open: NHMRC Biennial Awards 
NHMRC awards recognise outstanding leadership, innovation and sector contribution, and include the:

• Research Quality Award
• Consumer Engagement Award
• Ethics Award
• Outstanding Contribution Award
• Science to Art Award

Nomination deadline: 1 April 2020
Read more
 

Cancer Immunology Ideas Forum : Save the date
Immune checkpoint inhibitors, CAR-T cells and cancer vaccines are changing the way clinicians are managing malignancies, and the prognosis of people living with cancer. But it’s only the beginning. The inaugural Cancer Immunology Ideas Forum brings together the pre-clinical, translational and clinical research community for presentation of work, scientific discussion and research brainstorming.This will be a day of collegiality and collaboration for those working on this frontier of medicine.
When: 21 May 2021. Further details TBA.  
 

Funding

Business Innovation Challenge Funding: UNSW EOI
UNSW is working with industry partners and collaborative networks to identify and nominate three outstanding commercialisation proposals from small to medium businesses for the NSW R&D Innovation Districts Challenge. EOIs are open for businesses with a product or service that directly addresses the impact of COVID-19, and is a health and wellbeing solution for the people of NSW.
EOI Deadline: 8 March 2021
Read more
 

NHMRC participation in the 2021 e-Asia Joint Research Program   
NHMRC is participating in the 2021 e-ASIA Joint Research Program 10th Health Research call for research proposals in infectious diseases or cancer. To be eligible to apply for NHMRC funding, a research project must consist of Australian researchers partnering with at least two research teams from participating e-ASIA member organisations.
Deadline: 29 March 2021
Read more
 

MRFF Funding Opportunities

• 2020 Improving Diagnosis in Cancers with Low Survival Rates Deadline: 10 March 2021
• 2020 Paediatric Cancer  Deadline: 10 March 2021
• 2020 Neurofibromatosis Research Deadline: 7 April 202
   

NHMRC 2021 Funding Opportunities

• 2021 Investigator Grants Deadline: 31 March 2021
• Partnership Project 2021 PRC1 Deadline: 7 April 2021
• 2021 Synergy Grants Deadline: 21 April 2021
• 2021 Ideas Grants Deadline: 5 May 2021
   

Triple I Vision: A world where human health is enriched by controlling infection, enhancing immunity and managing inflammation.